Mirtazapine Tablet, Film Coated
Product Images NDC 70518-1838

2 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-1838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure diagram of the active ingredient Mirtazapine. The illustration shows the arrangement of rings and atoms characteristic of Mirtazapine's molecular composition.*
FDA Label Image

Mm1 (Mirtazapine 15mg 70518 1838 00)

Mm1 (Mirtazapine 15mg 70518 1838 00)
Mirtazapine 15 mg tablet label for a 30-count package. The label shows the product name, strength, quantity, NDC number 70518-1838-00, and mentions the tablets are yellow capsules. It indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer information includes Aurobindo Pharma, Dayton, NJ. Storage instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.